Biosensis' Rapid ELISA range delivers fast, accurate, and reproducible quantitative analysis for key neurodegenerative disease targets, including Alzheimer’s Disease (AD) and Amyotrophic Lateral Sclerosis (ALS). These kits enable detection of critical neurological targets across the entire neurotrophin signaling axis: Isoform-Specific Precision: Engineered for exceptional sensitivity, our Mature BDNF, proBDNF, and NGF Rapid ELISA kits quantify each isoform independently to cut out cross-reactivity. Receptor Axis Profiling: Seamlessly map receptor density and downstream signaling pathways across p75NTR, TrkA, TrkB, and TrkC. For added flexibility, our combination kits support parallel multi-target detection, optimizing assay efficiency while significantly reducing sample consumption.
